The Recall Desk
LowFDA (Drugs)·D-0198-2025·Announced 2025-01-22

Diphenhydramine HCl Capsules Recalled Due to Wrong ID Imprinting

Akron Pharma recalls 456 bottles of Diphenhydramine HCl 25 mg capsules due to incorrect ID imprinted on the capsules.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is purely a labeling and identification issue. FDA Class III recalls are typically scored 1 or 2; with no reported harm and a documentation-only issue, this recall merits a Low score.

Plain-English summary

Akron Pharma, Inc. is recalling Diphenhydramine HCl 25 mg capsules (1000 capsules per bottle) in Lot KDC0124002B with expiration 09/30/2026. The recall affects 456 bottles distributed nationwide in the United States.

The capsules were imprinted with incorrect identification information. This is a labeling issue that affects proper identification of the medication.

Consumers who have this product should verify the lot number KDC0124002B and expiration date 09/30/2026 on their bottles. Anyone with the recalled product should consult with their pharmacist or contact Akron Pharma for further instructions.

The recalled product

Product
Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.
Manufacturer
Akron Pharma, Inc.
Category
Drug
Hazard
  • mis-labeling

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot: KDC0124002B Exp 09/30/2026

Distribution

Distributed nationwide across the United States.

Related recalls

Same category